Latest / The BioHub - by Avetix
Episode 108 - JPM Special - Dirk Thye, CEO Quince Therapeutics
In our first JPM Special 2026, we’re joined by Dirk Thye, CEO of Quince Therapeutics, as the company approaches a defining Phase 3 readout. A candid conversation about high-stakes data, leadership under pressure, and what a true do-or-die moment looks like in biotech.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.